Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.83 USD | -1.70% | +19.96% | -37.36% |
04-12 | Vaccinex, Inc. announced that it has received $1.75 million in funding | CI |
04-02 | Vaccinex, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 275K 22.01M | Sales 2023 | 570K 45.63M | Capitalization | 8.31M 665M |
---|---|---|---|---|---|
Net income 2022 | -19M -1.52B | Net income 2023 | -20M -1.6B | EV / Sales 2022 | 95.4 x |
Net cash position 2022 | 5.91M 473M | Net cash position 2023 | 1.29M 103M | EV / Sales 2023 | 12.3 x |
P/E ratio 2022 |
-1.37
x | P/E ratio 2023 |
-0.21
x | Employees | 39 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
1 day | -1.70% | ||
1 week | +19.96% | ||
Current month | -21.32% | ||
1 month | -21.74% | ||
3 months | -35.84% | ||
6 months | -56.58% | ||
Current year | -37.36% |
Managers | Title | Age | Since |
---|---|---|---|
Maurice Zauderer
FOU | Founder | 78 | 31/12/96 |
Elizabeth Evans
COO | Chief Operating Officer | 52 | 30/04/01 |
Ernie Smith
CTO | Chief Tech/Sci/R&D Officer | 52 | 31/05/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bala S. Manian
BRD | Director/Board Member | 77 | 30/11/04 |
Albert Friedberg
CHM | Chairman | 77 | 31/12/96 |
Chrystyna Stecyk
BRD | Director/Board Member | 61 | 13/05/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 5.83 | -1.70% | 12,352 |
25/04/24 | 5.931 | +18.50% | 8,667 |
24/04/24 | 5.005 | +0.84% | 3,544 |
23/04/24 | 4.963 | +0.47% | 7,420 |
22/04/24 | 4.94 | +1.65% | 5,880 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotes- Stock Market
- Equities
- VCNX Stock